TIFFANY BRADY: Open Payments
NPI 1073249272 · COVINGTON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,334 in 135 payments from 20 companies in 2025. Trend: 2023 $345 · 2024 $1,270 · 2025 $2,334
Food & beverage: $2,334
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 18 | $293 |
| ViiV Healthcare Company | 10 | $283 |
| Otsuka America Pharmaceutical, Inc. | 12 | $248 |
| ABBVIE INC. | 15 | $235 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 28 | $174 |
| Alkermes, Inc. | 11 | $167 |
| Gilead Sciences, Inc. | 2 | $148 |
| Lundbeck LLC | 8 | $146 |
| Vanda Pharmaceuticals Inc. | 8 | $140 |
| Merck Sharp & Dohme LLC | 5 | $109 |
Products named: REXULTI, Auvelity, VRAYLAR, DOVATO, CAPLYTA, FANAPT, Biktarvy, PIFELTRO.
Industry payments across LA — which companies pay providers there.
